Revelation Biosciences Announces Adoption of Stockholder Rights Plan
Revelation Biosciences adopted a stockholder rights plan and declared a dividend of one right for each outstanding share of common stock to protect against coercive takeover tactics. The rights become exercisable if a person or group acquires 10% or more of the common stock without board approval, allowing other holders to purchase shares at a discount to market. CEO James M.
Key figures
- Record date
- July 21, 2026
- Trigger threshold
- 10%
- Rights exercise price
- 20
- Passive investor trigger
- 15%
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.